Abstract
The hematologic malignancies have long been recognized to be both morphologically and clinically heterogeneous. In the past decade, there have been significant advances in the identification and characterization of the cell surface molecules that are expressed on normal lymphoid and myeloid cells. The application of these markers to the study of leukemias and lymphomas has initiated an understanding of the heterogeneity and both the biologic and clinical behavior of these tumors. It is now possible to assign a lineage derivation to a neoplastic hematopoietic cell in virtually all cases by the expression of lineage-restricted antigens (Ags). More importantly, by using markers that define stages of normal T, B, and myeloid differentiation, it is possible to begin to identify subsets of patients within histologically defined subgroups of leukemias and lymphomas that demonstrate unique clinical presentations, disease courses, and responses to therapy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abramson, C., Kersey, J. H., and LeBien, T. W., 1981, A monoclonal antibody (BA-1) primarily reactive with cells of human B lymphocyte lineage, J. Immunol. 126:83–88
Acuto, O., and Reinherz, E. L., 1985, The human T-cell receptor: Structure and function, N. Engl. J. Med. 312:1100–1111
Aisenberg, A. C., Wilkes, B. M., and Harris, N. L., 1983, Monoclonal antibody studies in non-Hodgkin’s lymphoma, Blood 61:461–475
Allouche, M., Bourinbaiar, A., Georgoulias, V., Consolini, R., Salvatore, A., Auclair, H., and Jasmin, C., 1985, T cell lineage involvement in lymphoid blast crisis of chronic myeloid leukemia, Blood 66:1155–1161
Amiot, M., Dastot, H., Schmid, M., Bernard, A., and Boumsell, L., 1987, Analysis of CD1 molecules on thymus cells and leukemic T lymphoblasts identifies discrete phenotypes and reveals that CD1 intermolecular complexes are observed only on normal cells, Blood 70:676–685
Anderson, K. C., Park, K., Bates, M., Leonard, R. C. F., Hurdy, R., Schloosman, S. F., and Nadler, L. M., 1983, Antigens on human plasma cells identified by monoclonal antibodies, J. Immunol 130: 1132–1138
Anderson, K. C., Bates, M. P., Slaughenhoupt, B. L., Pinkus, G. S., O’Hara, C., Schlossman, S. F., and Nadler, L. M., 1984, Expression of human B cell associated antigens on leukemias and lymphomas: A model of B cell differentiation, Blood 63:1424–31
Anderson, K. C., Boyd, A. W., Fisher, D. C., Leslie, D., Schlossman, S. F., and Nadler, L. M., 1985, Hairy cell leukemia: A tumor of pre-plasma cells, Blood 65:620–629
Arnaout, M. A., Todd, R. F., Dana, N., Melamed, J., Schlossman, S. F., and Colter, H. R., 1983, Inhibition of phagocytes of complement C3 or IgG coated particles and of C3Gi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol), J. Clin. Invest. 72:171–179
Arnold, A., Cossman, J., Bakhshi, A., Jaffe, E. S., Waldmann, T. A., and Korsmeyer, S. J., 1983, Immunoglobulin-gene arrangements as unique clonal markers in human lymphoid neoplasms, N. Engl. J. Med. 309:1593–1599
Ault, K. A., Antin, J. H., Ginsburg, D., Orkin, S. H., Rappeport, J. M., Keohan, M. L., Martin, P., and Smith, B. R., 1985, Phenotype of recovering lymphoid cell populations after marrow transplantation, J. Exp. Med. 161:1483–1502
Baldini, L., DiPadova, F., Cortelezzi, A., Nori, A., Nobili, L., Lavezzi, A. M., Maiolo, A. T., and Polli, E. E., 1985, Functional and multimarker analysis of T cell chronic lymphocytic leukemia, Scand. J. Haematol. 34:88–96
Ball, E. D., and Fanger, M. W., 1983, The expression of myeloid-specific antigens on myeloid leukemia cells: Correlations with leukemia subclasses and implications for normal myeloid differentiation, Blood 61:456–463
Barber, E. K., Dasgupta, J. D., Schlossman, S. F., Trevillyan, J. M., and Rudd, C. E., 1989, The CD8 antigen is coupled to a protein-tyrosine kinase (p58Lck) that phosphorylates the CD3 complex in vitro, Tissue Antigens 33:93
Bernard, A., Boumsell, L., Reinherz, E. R., Nadler, L. M., Ritz, J., Coppin, H., Richard, Y., Valensi, F., Dausset, J., Flandrin, G., Lemerle, J., and Schlossman, S. F., 1981, Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: Evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma, Blood 57:1105–1110
Berribi, A., Dagan, S., Bassous-Guedj, L., Vorst, E., and Shtalrid, M., 1989, Further characterization of prolymphocytic leukemia cells as a tumor of activated B cells, Tissue Antigens 33:324
Bettelheim, P., Panzer, S., Majdic, O., Stockinger, H., Roithner, A., Köller, U., Meryn, S., Lechner, K., and Knapp, W., 1985a, Unexpected absence of a myeloid surface antigen (3-fucosyl-n-acetyllactosamine) in promyelocytic leukemia, Leuk. Res. 9:1323–1327
Bettelheim, P., Lutz, D., Majdic, O., Paietta, E., Haas, O., Linkesch, W., Neumann, E., Lechner, K., and Knapp, W., 1985b, Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia, Br. J. Haematol. 59:395–409
Bhan, A. K., Nadler, L. M., Stashenko, P., and Schlossman, S. F., 1981, Stages of B cell differentiation in human lymphoid tissues, J. Exp. Med. 154:737–749
Bofill, M., Janossy, G., Janossa, M., Burford, G. D., Seymour, G. J., Wernet, P., and Kelemen, E., 1985, Human B cell development. II. Subpopulations in the human fetus, J. Immunol. 134:1531–38
Borowitz, M. J., Dowell, B. L., Boyett, J. M., Falletta, J. M., Pullen, D. J., Crist, W. M., Humphrey, G. B., and Metzgar, R. S., 1985, Monoclonal antibody definition of T cell acute leukemia: A pediatric oncology group study, Blood 65:785–788
Boue, D. R., and LeBien, T. W., 1988, Expression and structure of CD22 in acute leukemia, Blood 71: 1480–1486
Boumsell, L., Coppin, H., Pham, D., Raynal, B., Lemerle, J., Dausset, J., and Bernard, A., 1980, An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells, J. Exp. Med. 152:229–234
Boumsell, L., Bernard, A., Reinherz, E. R., Nadler, L. M., Ritz, J., Coppin, H., Richard, Y., Dubertret, L., Valensi, F., Degos, L., Lemerle, J., Flandrin, G., Dausset, J., and Schlossman, S. F., 1981, Surface antigens on malignant Sezary and T-CLL cells correspond to those of mature T cells, Blood 57:526–530
Boyd, A. W., Anderson, K. C., Freedman, A. S., Fisher, D. C., Slaughenhoupt, B. L., Schlossman, S. F., and Nadler, L. M., 1985a, Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody, J. Immunol. 134:1516–1523
Boyd, A. W., Fisher, D. C., Fox, D., Schlossman, S. F., and Nadler, L. M., 1985b, Structural and functional characterization of IL-2 receptors on activated B cells, J. Immunol. 134:2387–92
Boyd, A. W., Tedder, T. F., Griffin, J. D., Freedman, A. S., Fisher, D. C., Daley, J., and Nadler, L. M., 1987, Pre-exposure of resting B cells to gamma interferon enhances their proliferative response to subsequent activation signals, Cell Immunol. 106:355–65
Bradley, T. R., and Metcalf, D., 1966, The growth of mouse bone marrow cells in vitro, Aust. J. Exp. Biol. Med. 44:287–300
Braesch-Anderson, S., Paulie, S., Aspenstrom, P., Koho, H., and Perlmann, P., 1989, Biochemical characteriztics of the human B-cell and carcinoma antigen CDw40, Tissue Antigens 33:129
Brenner, M. B., McLean, J., Dialynas, D. P., Strominger, J. L., Smith, J. A., Owen, F. L., Seidman, J. G., Ip, S., Rosen, F., and Krangel, M. S., 1986, Identification of a putative second T-cell receptor, Nature (London) 322:145–149
Broder, S., and Bunn, P. A., 1980, Cutaneous T cell lymphomas, Semin. Oncol. 7:310–331
Brooks, D. A., Beckman, I. G. R., Bradley, J., McNamara, P. J., Thomas, M. E., and Zola, H., 1981, Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes, J. Immunol. 126:1373–1377
Brouet, J. C., Preud’homme, J. L., Penit, C., Valensi, F., Rouget, P., and Seligmann, M., 1979, Acute lymphoblatic leukemia with pre-B cell characteristics, Blood 54:269–273
Brouet, J. C., Rabian, C., Gisselbrecht, C., and Flandrin, G., 1984, Clinical and immunological study of non-Hodgkin T cell lymphomas (cutaneous and lymphoblastic lymphomas excluded), Br. J. Haematol. 57:315–327
Brown, V., Smith, S., Dewar, E., and Maddy, A., 1987, The correlation between surface immunoglobulin expression and the leucocyte-common antigen in B-cell chronic lymphocytic leukaemia, Leuk. Res. 11:903–910
Cadman, E. C., Capizzi, R. L., and Bertino, J. R., 1977, Acute nonlymphocytic leukemia. A delayed complication of Hodgkin’s disease therapy. Analysis of 109 cases, Cancer 40:1280–1296
Caligaris-Cappio, F., Gobbi, M., Bofill, M., and Janossy, G., 1982, Infrequent normal B lymphocytes express features of B chronic lymphocytic leukemia, J. Exp. Med. 155:623–627
Caligaris-Cappio, F., Bergui, L., Tesio, L., Pizzolo, G., Malavasi, F., Chilosi, M., Campana, D., van Camp, B., and Janossy, G., 1985, Identification of malignant plasma cell precursors in the bone marrow of multiple myelome, J. Clin. Invest. 76:1243–1251
Campana, D., Sheridan, B., Tidman, N., Hoffbrand, A. V., and Janossy, G., 1986, Human leukocyte function-associated antigens on lympho-hematopoietic precurser cells, Eur. J. Immunol. 16:537–542
Campana, D., Thompson, J. S., Amlot, P., Brown, S., and Janossy, G., 1987, The cytoplasmic expression of CD3 antigens in normal and malignant cells of T lymphoid lineage, J. Immunol. 138:648–655
Catovsky, D., Pettit, J. E., Galetto, J., Okos, A., and Galton, D. A. G., 1974, The B-lymphocyte nature of the hairy cell of leukemic reticuloendotheliosis, Br. J. Haematol. 26:29–37
Catovsky, D., Cherchi, M., Okos, A., Hedge, U., and Galton, D. A. G., 1976, Mouse red blood cell rosettes in B lymphoproliferative disorders, Br. J. Haematol. 33:173–177
Catovsky, D., Cherchi, M., Brooks, D., Bradley, J., and Zola, H., 1981, Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC7, Blood 58:406–408
Catovsky, D., Wechsler, A., Matutes, E., Gomez, R., Bourikas, G., Cherchi, M., Pepys, E. O., Pepys, M. B., Kitani, T., Hoffbrand, A. V., and Greaves, M. F., 1982, The membrane phenotype of T-prolymphocytic leukemia, Scand. J. Haematol. 29:398–404
Charbonneau, H., Tonks, N. K., Walsh, K. A., and Fischer, E. H., 1988, The leukocyte common antigen (CD45): A putative receptor-linked protein tyrosine phosphatase, Proc. Natl. Acad. Sci. USA 85:7182–7186
Chen, Z., Sigaux, F., Miglierina, R., Valensi, F., Daniel, M. T., Ochoa-Noguera, M. H., and Flandrin, G., 1986, Immunological typing of acute lymphoblastic leukemia: Concurrent analysis by flow cytofluorometry and immunocytology, Leuk. Res. 10:1411–1417
Civin, C. I., Vanghan, W. P., Straa, L. C., Schwartz, J. F., Karp, J. E., and Burke, P. J., 1983, Diagnostic and prognostic utility of cell surface markers in acute non-lymphocytic leukemia (ANLL), Exp. Hematol. 11(Suppl. 14):152a
Clark, E. A., and Yokochi, T., 1984, Human B cell and B cell blast-associated surface molecules defined with monoclonal antibodies, in Leukocyte Typing I (A. Bernard et al., eds.), pp. 339–346, Springer-Verlag, Berlin
Clark, E. A., Shu, G., and Ledbetter, J. A. 1985, Role of the Bp35 cell surface polypeptide in human B-cell activation, Proc. Natl. Acad. Sci. USA 82:1766–1770
Clayberger, C., Medeiros, L. J., Link, M. P., Warnke, R. A., Wroght, A., Koller, T. D., Smith, S. D., and Krensky, A. M., 1987, Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance, Lancet ii:533–536
Cossman, J., and Jaffe, E. S., 1981, Distribution of complement receptor subtypes in non-Hodgkins lymphomas of B cell origin, Blood 58:20–26
Cossman, J., Neckers, L. M., Arnold, A., And Korsmeyer, S. J., 1982, Induction of differentiation in a case of common acute lymphoblastic leukemia, N. Engl. J. Med. 307:1251–1254
Cossman, J., Chused, T. M., Fisher, R. I., Magrath, I., Bollum, F., and Jaffe, E. S., 1983, Diversity of immunological phenotypes of lymphoblastic lymphoma, Cancer Res. 43:4486–4490
Cossman, J., Neckers, L. M., Jones, T., Hsu, S. M., Jaffe, E. S., 1984a, Low grade lymphomas: Expression of developmentally regulated B cell antigens, Am. J. Pathol. 115:117–124
Cossman, J., Jaffe, E. S., and Fisher, R. I., 1984b, Immunologic phenotypes of diffuse, aggressive, non-Hodgkin’s lymphomas: Correlations with clinical features, Cancer 54:1310–1317
Dallenbach, F., Josimovic-Alasevic, O., Durkop, H., Schwarting, R., Pizzolo, G., Diamantstein, T., Takasuki, K., and Stein, H., 1989, Soluble Ki-1 (CD30) antigen in the sera of patients with adult T cell lymphoma/leukemia: A marker of disease activity, Tissue Antigens 33:309
Davey, F. R., Mick, R., Nelson, D. A., MacCallum, J., Sobol, R. E., Royston, I., Cuttner, J., Ellison, R. R., and Bloomfield, C. D., 1988, Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen, Leukemia 2:420–428
Defrance, T., Aubry, J. P., Rousset, F., Vanberuliet, B., Bonnefoy, J. Y., Arai, N., Takebe, Y., Yokota, T., Lee, F., Aral, K., DeVries, J., and Banchereau, J., 1987, Human recombinant interleukin 4 induces FcE receptors (CD23) on normal human B lymphocytes, J. Exp. Med. 165:1459–1467
De la Hera, A., Alvarez-Mon, M., and Sanchez-Madrid, F., Martinez, A. C., and Durantez, A., 1988, Co-expression of Mac-1 and p150,95 on CD5+ B cells. Structural and functional characterization in a human chronic lymphocytic leukemia, Eur. J. Immunol. 18:1131–1134
Delia, D., Cattoretti, G., Polli, N., Fontanella, E., Aiello, A., Giardini, R., Rilke, F., and Della Porta, G., 1988, CD1c but neither CD1a nor CD1b molecules are expressed on normal activated, and malignant human B cells: Identification of an new B-cell subset, Blood 72:241–247
Dinndorf, P. A., and Reaman, G. H., 1986, Acute lymphoblastic leukemia in infants: Evidence for B cell origin of disease by use of monoclonal antibody phenotyping, Blood 68:975–978
Dinndorf, P. A., Andrews, R. G., Benjamin, D., Ridgway, D., Wolff, L., and Bernstein, I. D., 1986, Expression of normal myeloid-associated antigens by acute leukemia cells, Blood 67:1048–1053
Divine, M., Farcet, J. P., Gourdin, M. F., Tabilio, A., Vasconcelos, A., Andre, C., Jouault, A., Bouguet, J., and Reyes, F., 1984, Phenotype study of fresh and cultured hairy cells with the use of immunologic markers and electron microscopy, Blood 64:547–552
Dorken, B., Moldenhauer, G., Pezzutto, A., Schwartz, R., Feller, A., Kiesel, S., and Nadler, L. M., 1986, HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes, J. Immunol. 136:4470–4479
Dorken, B., Moldenhauer, G., Pezzutto, A., and Emmrich, F., 1989, Analysis of functional effects of B cell antibodies using an antigen specific assay: CD19 antibodies enhance Ig secretion, Tissue Antigens 33:142
Dorken, P., Pezzutto, A., and Hunstein, W., 1987, Expression of cytoplasmic CD22 in B cell ontogeny, in Leukocyte Typing III (A. J. McMichael, ed.), pp. 474–475 Oxford University Press, Oxford
Dow, L. W., Borella, Sen, L., Aur, R. J. A., George, S. L., Mauer, A. M., and Simone, J. V., 1977, Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia, Blood 50:671–682
Drexler, H. G., Sagawa, K., Menon, M., and Minowada, J., 1986, Reactivity pattern of “myeloid monoclonal antibodies” with emphasis on MCS-2, Leuk. Res. 10:17–23
Einfeld, D. A., Brown, J. P., Valentine, M. A., Clark, E. A., and Ledbetter, J. A., 1988, Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains, EMBO J. 7:711–717
Ellegaard, J., Kucharska-Pulczynska, M., and Hokland, P., 1987, Analysis of leukocyte differentiation antigens in blood and bone marrow from patients with Waldenstrom’s macroglobulinemia, in Leukocyte Typing III (A. J. McMichael, ed.), pp. 512–515, Oxford University Press, Oxford
Erber, W. N., Breton-Gorius, J., Villeval, J. L., Oscier, D. G., Bai, Y., and Mason, D. Y., 1987, Detection of cells of megakaryocyte lineage in hematological malignancies by imuno-alkaline phosphatase labelled smears with a panel of monoclonal antibodies, Br. J. Haematol. 65:87–94
Erikstein, B. K., Asheim, H. C., Smeland, E. B., Beiske, K., and Funderud, S., 1989, Characterization of a new monoclonal antibody HH2 which recognizes a cell cycle regulated antigen specific for human B-lymphocytes, Tissue Antigens 33:150
Favier, R., Morel, M. C., Potevin, F., Kaplan, C., and Lecompte, T., 1989, CD9 and GPIIa-IIIa: Their potential association and role on platelet activation, Tissue Antigens 33:350
Feller, A. C., Griesser, G. H., Mak, T., and Lennert, K., 1986, Lymphoepithelioid lymphoma (Lennert’s lymphoma) is a monoclonal proliferation of helper/inducer T cells, Blood 68:663–667
Ferrarini, M., Romagnani, S., Montesoro, E., Zicca, A., Del Prete, G. F., Nocera, A., Maggi, E., Leprini, A., and Grossi, E., 1983, A lymphoproliferative disorder of the large granular lymphocytes with natural killer activity, J. Clin. Immunol. 3:30–41
Fingeroth, J. D., Weis, J., Tedder, T. F., Strominger, J. L., Biro, P. A., and Fearon, D. T., 1984, Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2, Proc. Natl. Acad. Sci. USA 81:4510–4514
Flug, F., Dodson, L., Wolff, J., Guarini, L., Rausen, A., Wang, C. Y., and Knowles, D. M., 1985, B-lymphocyte associated antigen expression by non-B, non-T acute lymphoblastic leukemia, Leuk. Res. 9:1051–1058
Ford, R. J., Yoshimura, L., Morgan, J., Quesada, J., Montagna, R., and Maizel, A., 1985, Growth factor-mediated tumor cell proliferation in hairy cell leukemia, J. Exp. Med. 162:1093–1098
Fox, D. A., Hussey, R. E., Fitzgerald, K. A., Acuto, O., Poole, C., Palley, L., Daley, J. F., Schlossman, S. F., and Reinherz, E. L., 1984, Tal, a novel 105 kd human T cell activation antigen defined by a monoclonal antibody, J. Immunol. 133:1250–1256
Frade, R., Crevon, M. C., Barel, M., Vazquez, A., Kirkorian, L., Charriaut, C., and Galahand, P., 1985, Enhancement of human B cell proliferation by an antibody to the C3d receptor, the gp 140 molecule. Eur. J. Immunol. 15:73–76
Freedman, A. S., Boyd, A. W., Berrebi, A., Horowitz, J. C., Rosen, K. J., Slaughenhoupt, B., Levy, D., Daley, J., Levine, H., and Nadler, L. M., 1987c, Expression of B cell activation antigens on normal and malignant B cells, Leukemia 1:9–15
Freedman, A. S., Boyd, A. W., Anderson, K. C., Fisher, D. C., Schlossman, S. F., and Nadler, L. M., 1985a, B5, a new B cell restricted activation antigen, J. Immunol. 134:2228–2235
Freedman, A. S., Boyd, A. W., Anderson, K. C., Fisher, D. C., Pinkus, G. S., Schlossman, S. F., and Nadler, L. M., 1985b, Immunologic heterogeneity of diffuse large cell lymphoma, Blood 65:630–637
Freedman, A. S., Boyd, A. W., Bieber, F., Daley, F., Rosen, K., Horowitz, J., Levy, D., and Nadler, L. M., 1987a, Normal cellular counterparts of B cell chronic lymphocytic leukemia, Blood 70:418–27
Freedman, A. S., Freeman, G., Horowitz, J. C., Daley, J., and Nadler, L. M., 1987b, B7, a B cell restricted antigen which identifies pre-activated B cells, J. Immunol. 137:3260–3267
Freedman, A. S., Freeman, G., Whitman, J., Segil, J., Daley, J., and Nadler, L. M., 1988, Pre-exposure of human B cells to recombinant interleukin I enhances subsequent proliferation, J. Immunol. 141:3398–404
Freedman, A. S., Freeman, G., Whitman, J., Segil, J., Daley, J., and Nadler, L. M., 1989a, Studies of in vitro activated CD5+ B cells, Blood 73:202–208
Freedman, A. S., Freeman, G., Whitman, J., Segil, J., Daley, J., Levine, H., and Nadler, L. M., 1989b, Expression and regulation of CD5 on in vitro activated human B cells, Eur. J. Immunol. 19:849–855
Funderud, S., Blomhoff, H. K., Asheim, H. C., Beiske, K., Totterman, T., and Smeland, E. B., 1989, Characterization of a new non-clustered B cell specific antigen (FN1) preferentially expressed on resting cells, Tissue Antigens 33:151
Gathings, W. E., Lawton, A. R., and Cooper, M. D., 1977, Immunofluorescent studies on the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans, Eur. J. Immunol. 7:804–810
Goldstein, L. A., Zhou, D. F. H., Picker, L. J., Minty, C. N., Bargatze, R. F., Ding, J. F., and Butcher, E. C., 1989, A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins, Cell 56:1063–1072
Goldstein, M., Hoxie, J., Zembryki, D., Matthews, D., and Levinson, A. I., 1985, Phenotypic and functional analysis of B cell lines from patients with multiple myeloma, Blood 66:444–446
Gordon, J., Rowe, M., Walker, L., and Guy, G., 1986, Ligation of the CD23 p45 antigen triggers cell-cycle progression of activated B lymphocytes, Eur. J. Immunol. 16:1075–1080
Grant, B. W., Platt, J. L., Jacob, H. S., and Kay, N. E., 1986, Lymphocyte populations and tac-antigen in diffuse B-Cell lymphomas, Leuk. Res. 10:1271–1278
Greaves, M. F., Verbi, W., Vogler, L. B., Cooper, M., Ellis, R., Ganeshguru, K., Hoffbrand, V., Janossy, G., and Bollum, F. J., 1980, Antigenic and enzymatic phenotypes of the pre-B subclass of acute leukemia, Leuk. Res. 3:353–362
Greaves, M. F., Hariri, G., Newman, R. A., Sutherland, D. R., Ritter, M. A., and Ritz, J., 1983, Selective expression of the common acute lymphoblastic leukemia (gp100) antigen on immature lymphoid cells and their malignant counterparts, Blood 61:628–639
Greil, R., Gattringer, C., Schultz, T., Knapp, W., Radaskiewicz, T., Dierich, M. P., and Huber, H., 1986, Receptors for the third component of complement: Their association with maturation stage in non-Hodgkin’s lymphoma and their possible implication with the development of follicular structure, Clin. Exp. Immunol. 64:423–431
Griffin, J. D., Ritz, J., Nadler, L. M., and Schlossman, S. F., 1981, Expression of myeloid differentiation antigens on normal and malignant myeloid cells, J. Clin. Invest. 68:932–941
Griffin, J. D., Mayer, R. J., Weinstein, H. J., Rosenthal, D. S., Coral, F. S., Beveridge, R. P., and Schlossman, S. F., 1983a, Surface marker analysis of acute myeloblastic leukemia: Identification of differentiation-associated phenotypes, Blood 62:557–563
Griffin, J. D., Ritz, J., Beveridge, R. P., Lipton, J. M., Daley, J. F., and Schlossman, S. F., 1983b, Expression of MY7 antigen on myeloid progenitor cells, Int. J. Cell Cloning 1:33–48
Griffin, J. D., Tantravahi, R., Canellos, G. P., Wisch, J. S., Reinherz, E. L., Sherwood, G., Beveridge, R. P., Daley, J. F., Lane, H., and Schlossman, S. F., 1983c, T cell surface antigens in a patient with blast crisis of chronic myeloid leukemia, Blood 61:640–644
Griffin, J. D., Todd, R. F., Ritz, J., Nadler, L. M., Canellos, G. P., Rosenthal, D., Gallivan, M., Beveridge, R. P., Weinstein, H., Karp, D., and Schlossman, S. F., 1983d, Differentiation patterns in the blastic phase of chronic myeloid leukemia, Blood 61:85–91
Griffin, J. D., Linch, D., Sabbath, K. D., Larcom, P., and Schlossman, S. F., 1984, A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells, Leuk. Res. 8:521–534
Griffin, J. D., Davis, R., Nelson, D. A., Davey, F. R., Mayer, R. J., Schiffer, C., McIntyre, O. R., and Bloomfield, C. D., 1986, Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia, Blood 68:1232–1241
Grogan, T. M., Fielder, K., Rangel, C., Jolley, C. J., Wirt, D. P., Hicks, M. J., Miller, T. P., Brooks, R., Greenberg, B., and Jones, S., 1985, Peripheral T cell lymphoma: Aggressive disease with heterogeneous immunotypes, Am. J. Clin. Pathol. 83:279–288
Habeshaw, J. A., Lister, T. A., and Starsfeld, A. G., 1983, Correlation of transferrin receptor expression with histologic class and outcome in non-Hodgkin’s lymphoma, Lancet 1:498–501
Hanson, C. A., Gajl-Peczalska, J., Parkin, J. L., and Brunning, R. D., 1987, Immunophenotyping of acute myeloid leukemia using monoclonal antibodies and the alkaline phosphatase-antialkaline phosphatase technique, Blood 70:83–89
Harris, N. L., Nadler, L. M., and Bhan, A. K., 1984, Immunologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies, Am. J. Pathol. 117:262–272
Hattori, T., Uchiyama, T., Toibana, T., Takatsuki, K., and Uchino, H., 1981, Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies, Blood 58:645–647
Haynes, B. F., Eisenbarth, G. S., and Fauci, A. S., 1979, Human lymphocyte antigens: Production of a monoclonal antibody that defines functional thymus derived lymphocyte subsets, Proc. Natl. Acad. Sci. USA 76:5829–5833
Haynes, B. F., Hemler, M. E., Mann, D. L., Eisenberth, G. S., Shelhamer, J., Mostowski, H. S., Thomas, C. A., Strominger, J. L., and Fauci, A. S., 1981a, Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes, J. Immunol. 126:1409–1420
Haynes, B., Hemler, B. F., Cotner, T., Mann, D. L., Eisenberth, G. S., Strominger, J. L., and Fauci, A. S., 198lb, Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation. J. Immunol. 127:347–351
Haynes, B. F., Metgar, R. S., Minna, J. D., and Bunn, P. A., 1981c, Phenotypic characterization of cutaneous T cell lymphoma: Use of monoclonal antibodies to compare with other malignant T cells, N. Engl. J. Med. 304:1319–1323
Haynes, B. F., Hensley, L. L., and Jegasothy, B. U., 1982, Differentiation of human T lymphocytes. II. Phenotypic difference in skin and blood malignant T cell in cutaneous T cell lymphoma, J. Invest. Dermatol. 78:323–326
Hercend, T., Nadler, L. M., Pesando, J. M., Reinherz, E. L., Schlossman, S. F., and Riz, J., 1981, Expression of a 26,000 dalton glycoprotein on activated human T cells, Cell. Immunol. 64:192–199
Hercend, T., Griffin, J. D., Bensussan, A., Schmidt, R. E., Edson, M. A., Brennan, A., Murray, C., Daley, J. F., Schlossman, S. F., and Ritz, J., 1985, Generation of monoclonal antibodies to a human natural killer clone: Characterization of two natural killer cell-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes, J. Clin. Invest. 75:932–943
Hoelzer, D., Thiel, E., Loeffer, H., Buechner, T., Ganser, A., Heil, G., Koch, P., Freud, M., Diedrich, H., Ruehl, H., Machmeyer, G., Lipp, T., Nowrousian, M. R., Burkert, M., Gerecke, D., Pralle, H., Mueller, U., Lunscken, C., Fuelle, H., Ho, A. D., Kuechler, R., Busch, F. W., Schneider, W., Goerg, C., Emmerich, B., Braumann, D., Vaupel, H. A., von Paleske, A., Bartels, H., Neiss, A., and Messerer, D., 1988, Prognostic factors in a multicenter study for treatment of acute lymphoblatic leukemia in adults, Blood 71:123–131
Hogg, N., and Horton, M. A., 1987, Myeloid antigens: New and previously defined clusters, in Leukocyte Typing III (A. J. McMichael, ed.), pp. 576–602, Oxford University Press, Oxford
Hokland, P., Rosenthal, P., Griffin, J. D., Nadler, L. M., Daley, J. F., Hokland, M., Schlossman, S. F., and Ritz, J., 1983, Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA), J. Exp. Med. 157:114–129
Hokland, P., Nadler, L. M., Griffin, J. D., Schlossman, S. F., and Ritz, J., 1984, Purification of the common acute lymphoblastic leukemia antigen (CALLA) positive cells from normal bone marrow, Blood 64:662–666
Hokland, P., Ritz, J., Schlossman, S. F., and Nadler, L. M., 1985, Orderly expression of B cell antigens during the in vitro differentiation of non-malignant human pre-B cell, J. Immunol. 135:1746–1751
Horning, S. J., Doggert, R. S., Warnke, R. A., Dorfman, R. F., Cox, R. S., and Levy, R., 1984, Clinical relevance of immunologic phenotype in diffuse large cell lymphoma, Blood 63:1209–1215
Horning, S. J., Weiss, L. M., Crabtree, G. S., and Warnke, R. A., 1986, Clinical and phenotypic diversity of T cell lymphomas, Blood 67:1578–1582
Howard, F. D., Ledbetter, J. A., Wong, J., Bieber, C. P., Stinson, E. B., and Herzenberg, L. A., 1981, A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation, J. Immunol. 126:2117–2122
Hurwitz, C. A., Loken, M. R., Graham, M. L., Kzarp, J. E., Borowitz, M. J., Pullen, D. J., and Civin, C. I., 1988, Asynchronous antigen expression in B lineage acute lymphoblastic leukemia, Blood 72:299–307
Iida, K., Nadler, L. M., and Nussenzweig, V., 1983, The identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody, J. Exp. Med. 158:1021–1033
Ikuta, K., Takami, M., Kim, C. W., Honjo, T., Miyoshi, T., Tagaya, Y., Kawabe, T., and Yodoi, J., 1987, Human lymphocyte Fc receptor for IgE: Sequence homology of its cloned cDNA with animal lectins, Proc. Natl. Acad. Sci. USA 84:819–823
Inghirami, G., Wieczorek, R., Zhu, B., Silber, R., Dalla-Favera, R., and Knowles, D. M., 1988, Differential expression of LFA-1 molecules in non-Hodgkin’s lymphoma and lymphoid leukemia, Blood 72:1431–1434
Inui, S., Kaisho, T., Clark, E. A., Seed, B., Kikutani, H., and Kishimoto, T., 1989, Expression of intact and mutant CDw40 on murine lymphocytes (cytoplasmic portion is essential for signal transduction through CDw40), Tissue Antigens 33:133
Jaffe, E. S., and Berard, C. W., 1978, Lymphoblastic lymphoma, a term rekindled with new precision, Ann. Int. Med. 89:415–417
Jaffe, E. S., Shevach, E. M., Frank, M. M., Berard, C. W., and Green, I., 1974, Nodular lymphoma—evidence for origin from follicular B lymphocytes, N. Engl. J. Med. 290:814–819
Jimbow, K., Maeda, K., Ito, Y., Ishida, O., and Takami, T., 1985, Heterogeneity of cutaneous T-cell lympho- ma: Phenotypic and ultrastructural characterization of four unusual cases, Cancer 56:2458–2469
Kamoun, M., Kadin, M. F., Martin, P. J., Nettleton, J., and Hansen, J. A., 1981, A novel humen T cell antigen preferentially expressed on mature T cells and also on (B type) chronic lymphatic leukemic cells, J. Immunol. 127:987–996
Katz, F. E., Tindle, R., Sutherland, D. R., and Greaves, M. F., 1985, Identification of a membrane glycoprotein associated with haemopoietic progenitor cells, Leuk. Res. 9:191–198
Katz, F., Malcolm, S., Gibbons, B., Tilly, R., Lam, G., Robertson, M. E., Czepulkowski, B., and Chessells, J., 1988, Cellular and molecular studies on infant null acute lymphoblastic leukemia, Blood 71:1438–1447
Keating, M. J., 1982, Early identification of potentially cured patients with acute myelogenous leukemia—a recent challenge, in Adult Leukemias 1 (C. D. Bloomfield, ed.), pp. 237–263, Martinus Nijhoff, Boston
Kehrl, J. H., Muraguchi, A., and Fauci, A. S., 1984, Differential expression of Oell activation markers after stimulation of resting human B lymphocytes, J. Immunol. 132:2857–2861
Kersey, J. H., Sabad, A., Gajl-Peczalska, F., Hallgen, H. M., Yunis, E. J., and Nesbit, M. E., 1973, Acute lymphoblastic leukemic cells with T (thymus-derived) lymphoma markers, Science 182:1355–1356
Kersey, J. H., LeBien, T. W., Abramson, C. S., Newman, R., Sutherland, R., and Greaves, M., 1981, p24: A human hemopoietic progenitor and acute lymphoblastic leukemia-associated cell surface structure identi-fied with a monoclonal antibody, J. Exp. Med. 153:726–731
Kikutani, H., Inui, S., Sato, R., Barsumain, L. E., Owaki, H., Yamaski, K., Kaisho, T., Uchibayashi, N., Hardy, R. R., Hirano, T., Tsunasawa, S., Sakiyama, F., Suemura, M., and Kishimato, T., 1986, Mo-lecular structure of human lymphocyte receptor for immunoglobulin E, Cell 47:657–665
Kishimoto, T., 1985, Factors affecting B cell growth and differentiation, Annu. Rev. Immunol. 3:133–152
Koike, T., Aoki, S., Maruyama, S., Narita, M., Ishizuka, T., Imanaka, H., Adachi, T., Maeda, H., and Shibata, A., 1987, Cell surface phenotyping of megakaryoblasts, Blood 69:957–960
Korsmeyer, S. J., Hieter, P. A., Ravetch, J. V., Poplack, D. G., Waldmann, T. A., and Leder, P., 1981, Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B cells, Proc. Natl. Acad. Sci. USA 78:301–313
Korsmeyer, S. J., Arnold, A., Bakhshi, A., Ravetch, J. V., Siebenlist, V., Hieter, P. A., Sharrow, S. O., LeBien, T. W., Kersey, J. H., Poplack, D. G., Leder, P., and Waldman, T. A., 1983a, Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins, J. Clin. Invest. 71:301–313
Korsmeyer, S. J., Greene, W. C., Cossman, J., Hsu, S. M., Jensen, J. P., Neckers, L. M., Marshall, S. L., Bakhshi, A., Depper, J. M., Leonard, W. J., Jaffe, E. S., and Waldmann, T. A., 1983b, Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia, Proc. Natl. Acad. Sci. USA 80:4522–4526
Koziner, B., Gebhard, D., Denny, T., and Evans, R. L., 1982, Characterization of B cell type chronic lymphocytic leukemia cells by surface markers and a monoclonal antibody, Am. J. Med. 73:802–807
Kristensen, J. S., Ellegaard, J., and Hokland, P., 1987, A two-color flow cytometry assay for detection of hairy cells using monoclonal antibodies, Blood 70:1063–1068
Kvaloy, S., Langholm, R., Kaalhus, O., Michaelsen, T., Funderud, S., Foss Abrahamsen, A., and Godal, T., 1984, Transferrin receptor and B-lymphoblast antigen—their relationship to DNA synthesis, histology and survival in B-cell lymphomas, Int. J. Cancer 33:173–1777
Ledbetter, J. A., and Uckun, F. M., 1989, Expression of a functional CD3T-cell receptor complex on leukemic human T-cell precursers, Tissue Antigens 33:88
Linch, D. C., Allen, C., Beverley, P. C. L., Bynoe, A. G., Scott, C. S., and Hogg, N., 1984, Monoclonal antibodies differentiating between monocytic and nonmonocytic variants of AML, Blood 63:566–573
Ling, N. R., MacLennan, I. C. M., and Mason, D. Y., 1987, B-cell antigens: New and previously defined clusters, in Leukocyte Typing III (A. J. McMichael, ed.), pp. 302–335, Oxford University Press, Oxford
Link, M. P., Stewart, S. J., Warnke, R. A., and Levy, R., 1985, Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood T lymphoblasts malignancies, J. Clin. Invest. 76:248–253
Loiseau, P., Divine, M., Le Paslier, D., Marolleau, J. P., Farcet, J. P., Flandrin, G., Cohen, D., Degos, L., Sigaux, F., and Reyes, F., 1987, Phenotypic and genotypic heterogeneity in large granular lymphocyte expansion, Leukemia 1:205–209
Look, A. T., Ashmun, R. A., Shapiro, L. H., and Peiper, S. C., 1989, The human myeloid plasma membrane antigen CD13 (gp150) is identical to aminopeptidase N, Tissue Antigens 33:228
Loughran, T. P., Drayes, K. E., Starkebaum, G., Kidd, P., and Clark, E. A., 1987, Induction of NK activity in large granular lymphocyte leukemia: Activation with anti-CD3 monoclonal antibodies, Blood 69:72–78
Majdi, O., Bettelheim, P., Stockinger, H., Aberer, W., Liszka, K., Lutz, D., and Knapp, W., 1984, M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cells, Int. J. Cancer 33:617–623
Mann, R. B., Jaffe, E. S., Braylen, R. C., Nanba, K., Frank, M. M., Ziegler, J. L., Berard, C. W., 1976, Non-endemic Burkitt’s lymphoma: A B cell tumor related to germinal centers, N. Engl. J. Med. 295:685–691
Marlin, S. D., and Pringer, T. A., 1987, Purified intracellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte-functional antigen 1 (LFA-1), Cell 51:813–819
Martin, P. J., Hansen, J. A., Nowinski, R. C., and Brown, M. A., 1980, A new human T cell differentiation antigen: Unexpected expression on chronic lymphocytic leukemia cells, Immunogenetics 11:429–439
Martin, P. J., Hansen, J. A., Siadak, A. W., and Nowinski, R. C., 1981, Monoclonal antibodies recognizing normal human T lymphocytes and malignant B lymphocytes: A comparative study, J. Immunol. 127:1920–1923
Matutes, E., Parreira, A., Foa, R., and Catovsky, D., 1985, Monoclonal antibody OKT17 recognizes most cases of T-cell malignancy, Br. J. Haematol. 61:649–656
McMichael, A. J., and Gotch, F. M., 1987, T-cell antigens: New and previously defined clusters, in Leukocyte Typing III (A. J. McMichael, ed.), pp. 31–62, Oxford University Press, Oxford
Miedema, F., and Melief, J. M., 1986, Immunobiology of the expanded T cells in T-cell leukemia and T-gamma lymphocytosis, Leuk. Res. 10:469–474
Miedema, F., Tromp, J. F., Veer, M. B., Poppema, S., and Melief, C. J. M., 1985, Lymphocyte function-associated antigen 1 (LFA-1) is a marker of mature (immunocompetent) lymphoid cells. A survey of lymphoproliferative disease in man, Leuk. Res. 9:1099–1104
Miller, R. A., and Gralow, J., 1984, The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA), J. Immunol. 133:3408–3414
Mirro, J., Kitchingman, G., Behm, F. G, Murphy, S. B., and Goorha, R. M., 1987, T cell differentiation stages identified by molecular and immunologic analysis of the T cell receptor complex in childhood lymphoblastic leukemia, Blood 69:908–912
Moller, P., Moldenhauer, G., and Dorken, B., 1989, Workshop antibodies B29 (HD66) and B74 (CDIS-4) define a new B-cell antigen, Tissue Antigens 33:160
Moore, M. A. S., and Owen, J. T., 1967, Experimental studies on the development of the thymus, J. Exp. Med. 126:715–725
Morabito, F., Prasthofer, E. F., Dunlap, N. E., Grossi, C. E., and Tilden, A. B., 1987a, Expression of myelomonocytic antigen on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1, Blood 70:1750–1757
Morabito, F., Prasthofer, E. F., Pullen, D. J., Mahoney, D., Downing, J. R., Crist, W. M., and Grossi, C. E., 1987b, Analysis of surface antigen profile, TdT expression, and T cell receptor gene rearrangement for maturational staging of leukemic T cells: A pediatric oncology group study, Leukemia 1:514–517
Morimoto, C., Letvin, N. L., Distaso, J. A., Aldrich, W. R., and Schlossman, S. F., 1985a, The isolation and characterization of the human suppressor inducer T cell subset, J. Immunol. 134:1508–1515
Morimoto, C., Letvin, N. L., Boyd, A. W., Hagan, M., Brown, H. M., Kornacki, M. M., and Schlossman, S. F., 1985b, The isolation and characterization of the human helper inducer T cell subset, J. Immunol. 134:3762–3769
Meuer, S., Hussey, R., Fabbi, M., Fox, D., Acuto, O., Fitzgerald, K., Hodgdon, J., Protentis, J., Schlossman, S., and Reinherz, E., 1984, An alternative pathway of T cell activation: A functional role for the 50 KD T11 sheep erythrocyte receptor protein, Cell 39:897–906
Morimoto, C., Matsuyama, T., Oshige, C., Tanaka, H., Hercend, T., Reinherz, E. L., and Schlossman, S. F., 1985c, Functional and phenotypic studies of Japanese adult T cell leukemia cells, J. Clin. Invest. 75:836–843
Mossalayi, M. D., Bertho, J. M., Dalloul, A. H., Lecron, J. C., and Debre, P., 1989, CD7 is the earliest cell surface antigen detected on T cell lineage, Tissue Antigens 33:108
Murray, L. J., Habeshaw, J. A., Wiels, J., and Greaves, M. F., 1985, Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells, Int. J. Cancer 36:561–565
Nadler, L. M., Reinherz, E. L., Weinstein, H. J., D’Orsi, C. J., and Schlossman, S. F., 1980, Heterogeneity of T cell lymphoblastic malignancies, Blood 55:806–810
Nadler, L. M., Stashenko, P., Hardy, R., van Agthoven, A., Terhorst, C., and Schlossman, S. F., 1981a, Characterization of a B cell specific (B2) distinct from B1, J. Immunol. 126:1941–1947
Nadler, L. M., Stashenko, P., Ritz, J., Hardy, R., Pesando, J. M., and Schlossman, S. F., 1981b, A unique cell surface antigen identifying lymphoid malignancies of B cell origin, J. Clin. Invest. 67:134–40
Nadler, L. M., Ritz, J., Bates, M. P., Park, E. K., Anderson, K. C., Sallan, S. E., and Schlossman, S. F., 1982, Induction of human B cell antigens in non-T cell mute lymphoblastic leukemia, J. Clin. Invest. 70:433–442
Nadler, L. M., Anderson, K. C., Marti, G., Bates, M., Park, E., Daley, J. F., and Schlossman, S. F., 1983, B4, a human B cell associated antigen expressed on normal, mitogen activated, and malignant B lymphocytes, J. Immunol. 131:244–250
Nadler, L. M., Korsmeyer, S. J., Anderson, K. C., Boyd, A. W., Slaughenhoupt, B., Park, E., Jensen, J., Coral, F., Mayer, R. J., Salim, S. E., Ritz, J., and Schlossman, S. F., 1984, B cell origin of non-T cell acute lymphoblastic leukemia, J. Clin. Invest. 74:332–340
Nadler, L. M., Boyd, A. W., Park, E., Anderson, K. C., Fisher, D., Slaughenhoupt, B., Thorley-Lawson, D. A., and Schlossman, S. F., 1986, The B cell-restricted glycoprotein (B2) is the receptor for Epstein-Barr virus, in Leukocyte Typing II Vol. 2 (E. L. Reinherz, B. F. Haynes, L. M. Nadler, and I. D. Bernstein, eds.), pp. 509–518, Springer-Verlag, New York
Nasu, K., Said, J., and Vonderheid, S., 1985, Immunopathology of cutaneous T-cell lymphoma, Am. J. Pathol. 119:436–447
Neame, P. B., Soamboonsrup, P., Browman, G. P., Meyer, R. M., Benger, A., Wilson, W. E. C., Walker, I. R., Saeed, N., and McBride, J. A., 1986, Classifying acute leukemia by immunophenotyping: A combined FAB-immunologic classification of AML, Blood 68:1355–1362
Neckers, L. M., Yenokida, G., and James, S. P., 1984, The role of the transferrin receptor in human B lymphocyte activation, J. Immunol. 133:2437–1441
Nemerow, G. R., McNaughton, M. E., and Cooper, N. R., 1985, Binding of monoclonal antibody to the Epstein Barr virus (EBV) CR2 receptor induces activation and differentiation of human B lymphocytes, J. Immunol. 135:3068–3073
Nogiwa, E., Tamaki, K., Omine, O., and Maekawa, T., 1988, A monoclonal antibody with reaction spectrum covering acute leukemia and T lineage cells, Leuk. Res. 12:249–256
Orazi, A., Cattoretti, G., Polli, N., and Rilke, F., 1989, CD1c and CD23 expression distinguish chronic Blymphocytic leukemias from other chronic leukemias and leukemic lymphomas, Tissue Antigens 33:68
Oshimi, K., Hoshino, S., Takahashi, M., Akahoshi, M., Saito, H., Kobayashi, Y., Hirai, H., Takaku, F., Yahagi, N., Oshimi, Y., Horie, Y., and Mizoguchi, H., 1988, Ti (WT31)-negative, CD3-positive, large granular lymphocyte leukemia with nonspecific cytotoxicity, Blood 71:923–931
Owen, J. J. T., and Raff, M. C., 1970, Studies on the differentiation of thymus-derived lymphocytes, J. Exp. Med. 132:1216–1232
Owen, J. J. T., and Ritter, M. A., 1969, Tissue interactions in the development of thymus lymphocytes, J. Exp. Med. 129:431–437
Pallesen, G., Hamilton-Dutoit, S., and Plesner, T., 1989, LFA-1 in lymphomas: Absence in hairy cell leukemia. An analysis of the workshop panel of CD11a/18 clustered antibodies, Tissue Antigens 33:258
Pals, S. T., Horst, E., Ossekoppele, G. J., Figdor, C. G., Scheper, R. J., and Meijer, C. J. L. M., 1989, Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin’s lymphoma, Blood 73:885–888
Palutke, M., Eisenberg, L., Kaplan, J., Hussain, M., Kithier, K., Tabaczka, P., Mirchandani, I., and Tenenbaum, D., 1983, Natural killer suppressor T cell chronic lymphocytic leukemia, Blood 62:627–634
Pandolfi, F., Rossi, G. D., Semenzato, G., Quinti, I., Ranucci, A., De Sanctis, G., Lopez, M., Gasparotto, G., and Aiuti, F., 1982, Immunologic evaluation of T chronic lymphocyte leukemia cells: Correlations among phenotype, functional activities, and morphology, Blood 59:688–695
Pandolfi, F., De Rossi, G., Ranucci, A., Bonomo, G., Pasqualetti, D., Napolitano, M., and Manzari, V., 1985, Tac-positive, HTLV-negative, T helper phenotype chronic lymphocytic leukemia cells, Blood 65:1531–1537
Paul, W. E., Mizuguchi, J., Brown, M., Nakanishi, K., Hornbeck, P., Rabin, E., and Ohara, J., 1986, Regulation of B-lymphocytes activation, proliferation, and immunoglobulin secretion, Cell. Immunol. 99:7–13
Patarroyo, M., Clark, E. A., Prieto, J., Kantor, C., and Gahmberg, C. G., 1987, Identification of a novel adhesion molecule in human leukocytes by monoclonal antibody LB-2, FEBS Lett. 210:127–131
Patarroyo, M., Prieto, J., Betty, P. G., Clark, E. A., and Gahmberg, C. G., 1988, Adhesion-mediating molecules of human monocytes, Cell. Immunol. 113:278–289
Pezzutto, A., Dorken, B., Moldenhauer, G., and Clark, E. A., 1987, Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140, J. Immunol. 138:98–103
Pezzutto, A., Dorken, G., Rabinovitch, P. S., Snow, P., Reinherz, E., and Schlossman, S. F., 1986, CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin induced B cell activation and proliferation, J. Immunol. 138:2793–2799
Pezzutto, A., Shu, G. L., Barrett, T B, Ellingsworth, L., Dorken, B., and Clark, E. A., 1989, Downregulation of B cell activation by CD19 monoclonal antibodies vs inhibition by surface Ig F, receptor cross-linking or TGF-beta, Tissue Antigens 33:144
Picker, L. J., Medeiros, L. J., Weiss, L. M., Warnke, R. A., and Butcher, E. C., 1988, Expression of lymphocyte homing receptor antigen in non-Hodgkin’s lymphoma, Am. J. Pathol. 130:496–504
Pike, B. L., and Robinson, W. A., 1970, Human bone marrow colony growth in agar-gel, J. Cell. Physiol. 76:77–84
Pilarski, L. M., Mant, M. J., and Ruether, B. A., 1985, Pre-B cells in peripheral blood of multiple myeloma patients, Blood 66:416–422
Pilkington, G. R., Wolf, M. M., Matthews, J., Griffiths, J. D., Cooper, I. A., Forster, D. C., and Jose, D. G., 1989, Correlation of CD surface antigen phenotype with FAB subtype, remission induction and survival in AML patients, Tissue Antigens 33:243
Pinkus, G. S., and Said, J. W., 1978, Characterization of non-Hodgkin’s lymphomas using multiple cell markers: Immunologic, morphologic, and cytochemical studies of 72 cases, Am. J. Pathol. 94:349–380
Pinto, A., Zagonel, V., Carbone, A., Marotta, G., De Rosa, L., Bullian, P. L., Cirillo, D., Attadia, V., Colombatti, A., and Del Vecchio, L., 1989, Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells identifies a subset of patients with a varient CLL phenotype and different biologic and clinical features, Tissue Antigens 33:181
Porwit-Ksiazek, A., Christersson, B., Lindemalm, C., Mellstedt, H., Tribukait, B., Biberfeld, G., and Biberfeld, P., 1983, Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin’s lymphomas, Int. J. Cancer 32:667–674
Posnett, D. N., Wang, C. Y., Chiorazzi, N., Crow, M. K., and Kunkel, H. G., 1985, An antigen characteristic of hairy cell leukemia cells is expressed on certain activated B cells, J. Immunol. 133:1635–1640
Posnett, D. N., Folkl, R. J., and Wang, C. Y., 1987, A hairy cell leukemia associated antigen (HC2) has a distinct role in normal B cell differentiation, Leukemia 1:384–386
Preud’homme, J L, and Seligman, M., 1972, Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases, Blood 40:777–791
Prieto, J., Beatty, P. G., Clark, E. A., and Patarroyo, M., 1988, Molecules mediating adhesion of T and B cells, monocytes and granulocytes to vascular endothelial cell, Cell 63:631–637
Pui, C. H., Dahl, G. V., Melvin, S., Williams, D. L., Peiper, S., Mirro, J., Murphy, S. B., and Stass, S., 1984, Acute leukaemia with mixed lymphoid and myeloid phenotype, Br. J. Haematol. 56:121–130
Pui, C. H., Williams, D. L., Raimondi, S. C., Melvin, S. L., Behm, F. G., Look, A. T., Dahl, G. V., Rivera, G. K., Kalwinsky, D. K., Mirro, J., Dodge, R. K., and Murphy, S. B., 1986, Unfavorable presenting clinical and laboratory features are associated with Calla-negative non-T, non-B lymphoblastic leukemia in children, Leuk. Res. 10:1287–1292
Quesenberry, P., and Levitt, L., 1979, Hematopoietic stem cells, N. Engl. J. Med. 301:755–760
Rabin, E., Ohara, J., and Paul, W. E., 1985, B-cell stimulatory factor 1 activates resting B cells, Proc. Natl. Acad. Sci. USA 82:2935–2929
Reinherz, E. L., and Schlossman, S. F., 1980, The differentiation and functions of human T lymphocytes: A review, Cell 19:821–827
Reinherz, E. L., Nadler, L. M., Sallen, S. E., and Schlossman, S. F., 1979a, Subset derivation of T-cell acute lymphoblastic leukemia in man, J. Clin. Invest. 64:392–397
Reinherz, E. L., Nadler, L. M., Rosenthal, D. A., Moloney, W. C., and Schlossman, S. F., 1979b, T cell subset characterization of human T-CLL, Blood 53:1066–1075
Reynolds, C. W., and Foon, K. A., 1984, Ty-lymphoproliferative disease and related disorders in man and experimental animals: A review of the clinical, cellular and functional characteristics, Blood 64:1146–1158
Ritter, M. A., Sauvage, C. A., Pegram, S. M., Myers, C. D., Dalchau, R., and Fabre, J. W., 1985, The human leukocyte-common (LC) molecule: Dissection of leukemias using monoclonal antibodies directed against framework and restricted antigenic determinants, Leuk. res. 9:1249–1254
Ritz, J., Pesando, M., Notis-McConarty, J., Lazarus, H., and Schlossman, S. F., 1980, A monoclonal antibody to human acute lymphoblastic leukemia antigen, Nature (London) 283:583–585
Ritz, J., Nadler, L. M., Bhan, A. K., Notis-McConarty, J., Pesndo, J. M., and Schlossman, S. F., 1981, Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B cell and T cell lineage, Blood 58:648–652
Robb, R., Greene, W. C., and Rusk, C. M., 1984, Low and high affinity cellular receptors for interleukin-2, J. Exp. Med. 160:1126–1146
Rothlein, R., Dustin, M. L., Marlin, S. D., and Springer, T. A., 1986, A human intracellular adhesion molecule (ICAM-1) distinct from LFA-1, J. Immunol. 137:1270–1274
Rudd, C. E., Trevillyan, J. M., Dasgupta, J. D., Wong, L. L., and Schlossman, S. F., 1988, The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes, Proc. Natl. Acad. Sci. USA 85:5190–5194
Rudders, R. A., DeLellis, R. A., Ahl, E. T., Bernstein, S., and Begg, C. B., 1983, Adult non-Hodgkin’s lymphoma, correlation of cell surface markers phenotype with prognosis, the new working formulation, and the Rappaport and Lukes-Collins histomorphologic schemes, Cancer 52:2289–2299
Rümke, H., Miedema, F., Berge, I. J. M., Terpstra, F., van der Reijden, H. J., van de Griend, R. J., de Bruin, H. G. K., von dem Borne, A. E. G., Smit, J. W., Zeijlemaker, W. P., and Melief, C. J. M., 1982, Functional properties of T cells in patients with chronic T gamma lymphocytosis and chronic T cell neoplasia, J. Immunol. 129:419–426
Sabbath, K. D., Ball, E. D., Larcom, P., Davis, R. B., and Griffin, J. D., 1985, Heterogeneity of clonogenic cells in acute myeloblastic leukemia, J. Clin. Invest. 75:746–753
Sakai, K., Hattori, T., Sagawa, K., Yokoyama, M., and Takatsuki, K., 1987, Biochemical and functional characterization of MCS-2 antigen (CD13) on myeloid leukemic cells and polymorphonuclear leukocytes, Cancer Res. 47:5572–5576
Salter, D. M., Krajewski, A. S., and Cunningham, S., 1987, Activation and differentiation antigen expression in B cell non-Hodgkin’s lymphoma, J. Pathol. 154:209–222
San Miguel, J. F., Gonzales, M., Canizo, M. C., Anta, J. P., Zola, H., and Lopez Borrasca, A., 1986, Surface marker analysis in AML and correlation with FAB classification, Br. J. Haematol. 64:547–560
Schwarting, R., and Stein, H., 1989, AS-HCL 2: A monoclonal antibody reacting with a new determinant of human B cells, Tissue Antigens 33:161
Schwarting, R., Stein, H., and Wang, C. Y., 1985, The monoclonal antibodies alpha-S-HCL1 (alpha-Leu-14) and alpha-S-HCL3 (alpha-Leu-M5) allow the diagnosis of hairy cell leukemia, Blood 65:974–983
Schwarzinger, I., Valent, P., Koller, U., Knapp, W., Lechner, K., and Bettelheim, P., 1989, Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloid leukemia, Tissue Antigens 33:245
Selvaraj, P., Plunkett, M. L., Dustin, M., Sanders, M. E., Shaw, S., and Springer, T. A., 1987, The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3, Nature (London) 326:400–403
Sheibana, K., Winberg, C. D., Van de Velde, S., Blaney, D. W., and Rappaport, H., 1987, Distribution of lymphocytes with IL-2 receptors (Tac antigen) in reactive lymphoproliferative processes, Hodgkin’s disease, and non-Hodgkin’s lymphoma, Am. J. Pathol. 127:27–37
Shipp, M. A., Richardson, N. E., Sayre, P. H., Brown, N. R., Masteller, E. L., Clayton, L. K., Ritz, J., and Reinherz, E. L., 1988, Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein, Proc. Natl. Acad. Sci. USA 85:4819–4823
Shipp, M. A., Vijayaraghavan, J., Schmidt, E. V., Masteller, E. L., D’Adamio, L., Hersh, L. B., and Reinherz, E. L., 1989, Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 (“enkephalinase”): Direct evidence by cDNA transfection analysis, Proc. Natl. Acad. Sci. USA 86:297–301
Simpkins, H., Kiprov, D. D., Davis, J. L., Morand, P., Puri, S., and Grahn, E. P., 1985, T cell chronic lymphocytic leukemia with lymphocytes of unusual immunologic phenotype and function, Blood 65:127–133
Small, T. N., Keever, C. A., Knowles, R. W., O’Reilly, R. J., and Flomenberg, N., 1989, CD1c expression during normal B cell ontogeny, Tissue Antigens 33:71
Snapper, C. M., and Paul, W. E., 1987, Interferon-y and B cell stimulatory factor-1 reciprocally regulate Ig isotype production, Science 236:944–947
Sobol, R. E., Roystan, I., LeBien, T., Minowada, J., Anderson, K., Davey, F. R., Cuttner, J., Schiffer, C., Ellison, R. R., and Bloomfield, C. D., 1985, Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies, Blood 65:730–735
Sobol, R. E., Mick, R., Royston, I., Davey, F. R., Ellison, R. R., Newman, R., Cuttner, J., Griffin, J. D., Collins, H., Nelson, D. A., and Bloomfield, C. D., 1987, Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia, N. Engl. J. Med. 316:1111–1117
Spier, C. M., Lippman, S. M., Miller, T. P., and Grogan, T. M., 1988, Lennert’s lymphoma, a clinicopathologic study with emphasis on phenotype and its relationship to survival, Cancer 61:517–524
Stamenkovic, I., and Seed, B., 1988a, CD19, the earliest differentiation antigen of B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus related cytoplasmic tail, J. Exp. Med. 168:1205–1210
Stamenkovic, I., and Seed, B., 1988b, Analysis of two cDNA clones encoding the B lymphocyte antigen CD20 (Bl, Bp35), a type III integral membrane protein, J. Exp. Med. 167:1975–1980
Stamenkovic, I., Amiot, M., Pesando, J. M., and Seed, B., 1989a, A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family, Cell 56:1057–1062
Stamenkovic, I., and Seed, B., 1990, The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion, Nature 345:74–77.
Stark, A. N., Limbert, H. J., Roberts, B. E., Jones, R. A., and Scott, C. S., 1986, Prolymphocytoid transfor-mation of CLL: A clinical and immunological study of 22 cases, Leuk. Res. 10:1225–1232
Stashenko, P., Nadler, L. M., Hardy, R., and Schlossman, S. F., 1980, Characterization of a new B lymphocyte specific antigen in man, J. Immunol. 125:1678–1685
Stashenko, P., Nadler, L. M., Hardy, R., and Schlossman, S. F., 1981, Expression of cell surface markers following human B cell activation, Proc. Natl. Acad. Sci. USA 78:3848–3852
Stein, H., Siemssen, V., and Lennert, K., 1978, Complement receptor subtypes C3b and C3d in lymphocytic tissue and follicular lymphoma, Br. J. Cancer 37:520–532
Stein, H., Gerdes, J., and Mason, D. Y., 1982, The normal and malignant germinal centre, Clin. Haematol. 11:531–559
Stein, H., Perez-Canto, A., Anagnostopoulis, I., Dallenbach, F., Dienemann, D., and Lemke, H., 1989, Expres- sion of the activation antigen Ki-24 by reactive and neoplastic lymphoid cells, Tissue Antigens 33:322
Sterry, W., and Mielke, V., 1989, In reactive skin diseases and cutaneous T cell lymphomas CD4+ memory cells [CD45R/2H4-, CDw29(4B4)+] are the dominating cell type, Tissue Antigen 33:278
Stonesifer, K. J., Benson, N. A., Ryden, S. E., Pawlinger, D. F., and Braylan, R. C., 1986, The malignant cells in a Lennert’s lymphoma are T lymphocytes with a mature helper surface phenotype. A multi-parameter flow cytometric analysis, Blood 68:426–429
Strauss, L. C., and Civin, C. I., 1983, MY10, a human progenitor cell surface antigen identified by a monoclonal antibody, Exp. Hematol. 11(Suppl. 14):370a
Strauss, L. C., Skubitz, K. M., August, J. T., and Civin, C. I., 1984, Antigenic analysis of hematopoiesis: II. Expression of human neutrophil antigens on normal and leukemic marrow cells, Blood 63:574–578
Streuli, M., Hall, L. R., Saga, Y., Schlossman, S. F., and Saito, H., 1987, Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens, J. Exp. Med. 166:1548–1566
Stutman, O., and Good, R. A., 1971, Immunocompetence of embyronic hematopoietic cells after traffic to thymus, Transplant. Proc. 3:923–925
Suzuki, T., Sanders, S. K., Butler, J. L., Gartland, G. L., Komiyama, K., and Cooper, M. D., 1986, Identification of an early activation antigen (Bac-1) on human B cells, J. Immunol. 137:1208–1213
Swendeman, S. L., and Thorley-Lawson, D. A., 1987, The activation antigen Blast-2, when shed is a BDGF for normal and transformed B-lymphocytes, in Leukocyte Typing III (A. J. McMichael, ed.), pp. 453–454, Oxford University Press, Oxford
Tagawa, S., Konishi, I., Kuratune, H., Katagiri, S., Taniguchi, N., Tamaki, T., Inoue, R., Kanayama, Y., Tsubakio, T., Machii, T., Yonezawa, T., and Kitani, T., 1983, A case of T cell chronic lymphocytic leukemia (T-CLL) expressing a peculiar phenotype (E+, OKM1+, Leu 1+, OKT3-, and IgG EA-), Cancer 52:1378–1384
Tagawa, S., Taniguchi, N., Tokumine, Y., Tamaki, T., Konishi, I., Kanayama, Y., Inoue, R., Machii, T., and Kitani, T., 1986a, OKM1-positive T-cell leukemias: Relationships among morphologic features, phenotype, and functional activities, Cancer 57:1507–151499
Tagawa, S., Tokumine, Y., Ueda, E., Waki, K., Kanayama, Y., Taniguchi, N., Nakanishi, T., Inoue, R., and Kitani, T., 1986b, Leu 11 + Tγ cell chronic lymphocytic leukemia with partially activated natural killer function and its further activation by recombinant IL2 in vitro, Blood 68:846–852
Tedder, T. F., Boyd, A. W., Freedman, A. S., and Nadler, L. M., 1985, The B cell surface molecule B1 is functionally linked with B cell activation and differentiation, J. Immunol. 135:973–979
Tedder, T. F., Streuli, M., Schlossman, S. F., and Saito, H., 1988, Isolation and structure of a cDNA encoding the B1 (CD20) cell surface antigen of human B lymphocytes, Proc. Natl. Acad. Sci. USA 85:208–212
Tedder, T. F., Bell, P. D., Frizzell, R. A., and Bubien, J. K., 1989a, CD20 directly regulates transmembrane ion flux in B lymphocytes, Tissue Antigens 33:145
Tedder, T. F., Penta, A., and Isaacs, C., 1989b, Cloning of CD19, a family of immunoglobulin-like proteins, and use of transfected cell lines to examine the workshop panel of monoclonal antibodies, Tissue Antigens 33:140
Terhorst, C., van Agthoven, A., LeClair, K., Ledbetter, J. A., Moldenhauer, G., and Clark, E. A., 1981, Biochemical studies in the human thymocyte antigens T6, T9, and T10, Cell 23:771–780
Tetteroo, P. A. T., van’t Veer, M. B., Tromp, J. F., and von dem Borne, A. E. G., 1984, Detection of the granulocyte-specific antigen 3-fucosyl-N-acetyl-lactosamine on leukemic cells after neuraminidase treatment, Int. J. Cancer 33:355–358
Thompson, L. F., Ruedi, J. M., Glass, A., and Lucas, A. H., 1989, Production of monoclonal antibodies to ecto-5’-nucleotidase: A glycosylphosphatidylinositol anchored differentiation antigen expressed on human T and B lymphocytes, Tissue Antigens 33:163
Thorley-Lawson, D. A., Schooley, R. T., Bhan, A. K., and Nadler, L. M., 1982, Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST-1) expressed on transformed lymphoblasts, Cell 30:415–425
Thorley-Lawson, D. A., Nadler, L. M., Bhan, A. K., Schooley, R. T., 1985, Blast-2 (EBVCS) an early cell surface marker of human B cell activation, is superinduced by Epstein-Barr virus, J. Immunol. 134:3007–3012
Till, J. E., and McCulloch, E. A., 1980, Hematopoietic stem cell differentiation, Biochim Biophys Acta 605:431–459
Tindle, R. W., Nichols, R. A. B., Chan, L., Campana, D., Catovsky, D., and Birnie, G. D., 1985, A novel monoclonal antibody BI-3C5 recognizes myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow, Leuk. Res. 9:1–9
Todd, R. F., Nadler, L. M., and Schlossman, S. F., 1981, Antigens on human monocytes identified by monoclonal antibodies, J. Immunol. 126:1435–1442
Tsai, L. C., Tsai, C. C., Hyde, T. P., Thomas, L. A., and Broun, G. O., 1984, T cell prolymphocytic leukemia with helper-cell phenotype and a review of the literature, Cancer 54:463–470
Tsudo, M., Uchiyama, T., and Uchino, H., 1984, Expression of TAC antigen on activated normal human B cells, J. Exp. Med. 160:612–617
Tsudo, M., Uchiyama, T., Uchino, H., and Yodoi, J., 1986, Failure of regulation of Tac antigen/TCGF receptor on adult T-cell leukemia cells by anti-Tac monoclonal antibody, Blood 61:1014–1016
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., and Uchino, H., 1977, Adult T-cell leukemia: Clinical and hematologic features of 16 cases, Blood 50:481–492
Uchiyama, T., Broder, S., and Waldmann, T. A., 1981, A monoclonal antibody (anti-TAC) reactive with activated and functionally mature T cells. I. Production of anti-TAC monoclonal antibody and distribution of Tac (+) cells, J. Immunol. 126:1393–1403
Uchiyama, T., Hori, T., Tsudo, M., Wano, Y., Umadome, H., Tamori, S., Yodoi, J., Maeda, M., Sawami, H., and Uchino, H., 1985, Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells, J. Clin. Invest. 76:446–453
Uckun, F., and Ledbetter, J. A., 1989a, Altered function of the CD19 receptor on leukemic human B-cell precursers in B-lineage acute lymphoblastic leukemia, Tissue Antigens 33:146
Uckun, F., and Ledbetter, J. A., 1989b, Expression and function of CDw40/Bp50 antigen in early human B-lymphocyte ontogeny, Tissue Antigens 33:146
Uckun, F. M., Waddick, K., Kuebelbeck, V., Ledbetter, J., Kishimoto, T., and Koller, B., 1989, Biphenotypic normal and leukemic lymphocyte precursers, Tissue Antigens 33:183
Van der Reijden, H. J., van Rhenen, D. J., Lansdorp, P. M., van’t Veer, M. B., Langenhuijsen, M. M. A. C., Engelfriet, C. P., and K. von dem Borne, A. E. G., 1983, A comparison of surface marker analysis and FAB classification in acute myeloid leukemia, Blood 61:443–448
Van der Valk, P., van den Besselaar-Dingjan, G., Daha, M. R., and Meijer, C. J. L. M., 1983, Analysis of large cell lymphomas using monoclonal and heterologous antibodies, J. Clin. Pathol. 36:44–50
Van Dongen, J. J. M., Krissansen, G. W., Wolvers-Tettero, I. L. M., Comans-Bitter, W. M., Adriaansen, H. J., Hooijkaas, H., van Wering, E. R., and Terhorst, C., 1988, Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies, Blood 71:603–612
Varon, D., Gittel, S., Linder, S., Bassous-Guedj, L., Vorst, E., and Berrebi, A., 1989, An antiplatelet glycoprotein IIb monoclonal antibody (3B2) interacts with activated platelets and recognizes immature megakaryoblasts, Tissue Antigens 33:347
Vodinelich, L., Tax, W., Bai, Y., Pegram, S., Capel, P., and Greaves, M. F., 1983, A monoclonal antibody (WT1) for detecting leukemias of T cell precursors (T-ALL), Blood 62:1108–1113
Vogler, L. B., Crist, W. M., Bockman, D. E., Pearl, E. R., Lawton, A. R., and Cooper, M. D., 1978, Pre-B cell leukemia; a new phenotype of childhood lymphoblastic leukemia, N. Engl. J. Med. 298:872–878
Volk, J. R., Kjeldsberg, C. R., Eyre, H. J., and Marty, J., 1983, T cell prolymphocytic leukemia: Clinical and immunologic characterization, Cancer 52:2049–2054
Waldmann, T. A., Greene, W. C., San, P. S., Saxinger, C., Blayney, D. W., Blattner, W. A., Goldman, C. K., Bongiovanni, K., Sharrow, S., Depper, J. M., Leonard, W., Uchiyama, T., and Gallo, R. C., 1984, Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sezary leukemia, and their distinction using anti-Tac, J. Clin. Invest. 73:1711–1718
Weisenberger, D. D., Linder, J., Daley, D. T., and Armitage, J. O., 1987a, Intermediate lymphocytic lymphoma. An immunohistologic study with comparison to other lymphocytic lymphomas, Human Pathol. 18:781–790
Weisenberger, D. D., Sanger, W. G., Armitage, J. O., and Purtilo, D. T., 1987b, Intermediate lymphocytic lymphoma: Immunophenotypic and cytogenetic findings, Blood 69:1617–1621
Weiss, L. M., Bindl, J. M., Picozzi, V. J., Link, M. P., and Warnke, R. A., 1986, Lymphoblastic lymphoma: An immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia, Blood 67:474–478
Wilson, B. S., Platt, J. L., and Kay, N. E., 1985, Monoclonal antibodies to the 140,000 mol wt glycoprotein of B lymphocyte membranes (CR2 receptor) initiates proliferation of B cells in vitro, Blood 66:824–829
Winberg, C. D., Sheibani, K., Krance, R., and Rappaport, H., 1985, Peripheral T cell lymphoma: Immu- nologic and cell-kinetic observations associated with morphological progression, Blood 66:980–989
Woermann, B., Anderson, J. M., Ling, Z. D., and LeBien, T. W., 1987, Structure/function analysis of IL-2 binding proteins on human B cell precursor acute lymphoblastic leukemia, Leukemia 1:660–666
Woods, G. M., Sawyer, P. J., Kirov, S. M., Lowenthal, R. M., Jupe, D. M., and Catovsky, D., 1985, Functional and phenotypic analysis of a T cell prolymphocytic leukemia, Leukemia Res. 9:587–596
Yagita, H., Nakamura, T., Karasuyama, and Okumura, K., 1989, Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells, Proc. Natl. Acad. Sci. USA 86:645–649
Yamada, Y., Kamihira, S., Amagasaki, T., Kinoshita, K., Kusano, M., Ikeda, S., Toriya, K., Suzuyama, J., and Ichimaru, M., 1984, Changes of adult T cell leukemia cell surface antigens at relapse or at exacerbation phase after chemotherapy defined by use of monoclonal antibodies, Blood 64:440–444
Yamada, Y., Kamihira, S., Amagasaki, T., Kinoshita, K., Kusano, M., Chiyoda, S., Yawo, E., Ikeda, S., Suzuyama, J., and Ichimaru, M., 1985, Adult T cell leukemia with atypical surface phenotypes: Clinical correlation, J. Clin. Oncol. 3:782–788
Yokochi, T., Holly, R. D., and Clark, E. A., 1982, B lymphoblast antigen (BBI) expressed on Epstein-Barr virus-activated B cell blasts. B lymphoblastoid cell lines, and Burkitt’s lymphomas, J. Immunol. 128:823–827
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Freedman, A.S. (1991). Cell Surface Markers in Leukemia and Lymphoma. In: Harris, J.R. (eds) Blood Cell Biochemistry Volume 3. Blood Cell Biochemistry, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3796-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3796-0_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6692-8
Online ISBN: 978-1-4615-3796-0
eBook Packages: Springer Book Archive